Specifically, we wanted to determine why the physiological relevance of MuRF2-mediated degradation (with MuRF2:PPARg1 at levels 10:1) in vivo did not appear relevant in the context of diabetic cardiomyopathy. Here, TRIM63 is linked to diabetic cardiomyopathy.